Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen

Maturitas

Volumn 53, Issue 4, 2006, Pages 371-379

  Rapuri, P B ^a   Gallagher, J C ^a   Knezetic, J A ^a   Haynatzka, V ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMD; Bone loss; Bone markers; Estrogen receptor genotypes; Hormone therapy

Indexed keywords

BIOCHEMICAL MARKER; ESTROGEN; ESTROGEN RECEPTOR ALPHA;

AGED; ARTICLE; BONE DENSITY; BONE REMODELING; CONTROLLED STUDY; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GENOTYPE; HORMONAL THERAPY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OSTEOLYSIS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; SKELETAL MUSCLE;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CALCITRIOL; DIET RECORDS; DOUBLE-BLIND METHOD; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; LONGITUDINAL STUDIES; MEDROXYPROGESTERONE 17-ACETATE; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC;

EID: 33644624542     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.07.007     Document Type: Article

References (36)

1. P.J. Kelly, J.L. Hopper, G.T. Macaskill, N.A. Pocock, P.N. Sambrook, and J.A. Eisman Genetic factors in bone turnover J Clin Endocrinol Metab 72 4 1991 808 813
2. P.J. Kelly, N.A. Morrison, P.N. Sambrook, T.V. Nguyen, and J.A. Eisman Genetic influences on bone turnover, bone density and fracture Eur J Endocrinol 133 3 1995 265 271
3. E.A. Krall, and B. Dawson-Hughes Heritable and life-style determinants of bone mineral density J Bone Miner Res 8 1 1993 1 9
4. N.A. Pocock, J.A. Eisman, J.L. Hopper, M.G. Yeates, P.N. Sambrook, and S. Eberl Genetic determinants of bone mass in adults. A twin study J Clin Invest 80 3 1987 706 710
5. D.M. Smith, W.E. Nance, K.W. Kang, J.C. Christian, and C.C. Johnston Jr. Genetic factors in determining bone mass J Clin Invest 52 11 1973 2800 2808
6. Y.Z. Bagger, H.L. Jorgensen, A.M. Heegaard, L. Bayer, L. Hansen, and C. Hassager No major effect of estrogen receptor gene polymorphisms on bone mineral density or bone loss in postmenopausal Danish women Bone 26 2 2000 111 116
7. K. Han, J. Choi, and I. Moon Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women Osteoporos Int 9 4 1999 290 295
8. K.O. Han, I.G. Moon, Y.S. Kang, H.Y. Chung, H.K. Min, and I.K. Han Non-association of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women J Clin Endocrinol Metab 82 4 1997 991 995
9. A.Y. Ho, S.S. Yeung, and A.W. Kung PvuII polymorphisms of the estrogen receptor alpha and bone mineral density in healthy southern Chinese women Calcif Tissue Int 66 6 2000 405 408
10. S. Kobayashi, S. Inoue, T. Hosoi, Y. Ouchi, M. Shiraki, and H. Orimo Association of bone mineral density with polymorphism of the estrogen receptor gene J Bone Miner Res 11 3 1996 306 311
11. H. Mizunuma, T. Hosoi, and H. Okano Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women Bone 21 5 1997 379 383
12. T. Salmen, A.M. Heikkinen, and A. Mahonen Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy J Bone Miner Res 15 2 2000 315 321
13. M. Sowers, M.L. Jannausch, W. Liang, and M. Willing Estrogen receptor genotypes and their association with the 10 year changes in bone mineral density and osteocalcin concentrations J Clin Endocrinol Metab 89 2 2004 733 739
14. C. Vandevyver, J. Vanhoof, and K. Declerck Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women J Bone Miner Res 14 9 1999 1576 1582
15. J.P. Ioannidis, I. Stavrou, and T.A. Trikalinos Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis J Bone Miner Res 17 11 2002 2048 2060
16. J.P. Ioannidis, S.H. Ralston, and S.T. Bennett Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes JAMA 292 17 2004 2105 2114
17. R. Sapir-Koren, G. Livshits, and E. Kobyliansky Genetic effects of estrogen receptor alpha and collagen IA1 genes on the relationships of parathyroid hormone and 25 hydroxyvitamin D with bone mineral density in Caucasian women Metabolism 52 9 2003 1129 1135
18. B. Ongphiphadhanakul, S. Chanprasertyothin, and P. Payatikul Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women Clin Endocrinol (Oxford) 52 5 2000 581 585
19. T. Salmen, A.M. Heikkinen, and A. Mahonen The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women J Bone Miner Res 15 12 2000 2479 2486
20. N. Kobayashi, T. Fujino, and T. Shirogane Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen Maturitas 41 3 2002 193 201
21. J.C. Gallagher, S.E. Fowler, J.R. Detter, and S.S. Sherman Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss J Clin Endocrinol Metab 86 8 2001 3618 3628
22. J.G. Haddad, and K.J. Chyu Competitive protein-binding radioassay for 25-hydroxycholecalciferol J Clin Endocrinol Metab 33 6 1971 992 995
23. T.A. Reinhardt, and R.L. Horst Simplified assays for the determination of 25OHD, 24,25(OH)2D and 1,25(OH)2D A.W. Norman K. Schaefer H.G. Grigoleit D.V. Herrath Vitamin D, molecular, cellular and clinical endocrinology 1988 Walter de Gruyter & Co. Berlin, Newyork 720 726
24. S.R. Nussbaum, R.J. Zahradnik, and J.R. Lavigne Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia Clin Chem 33 8 1987 1364 1367
25. S. Khosla, L.J. Melton III, E.J. Atkinson, W.M. O'Fallon, G.G. Klee, and B.L. Riggs Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen J Clin Endocrinol Metab 83 7 1998 2266 2274
26. J.C. Oi, N.A. Morrison, and T.V. Nguven Estrogen receptor genotypes and bone mineral density in women and men J Bone Miner Res 10 1995 [Abstract]
27. L. Gennari, L. Becherini, and L. Masi Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density J Clin Endocrinol Metab 83 3 1998 939 944
28. M. Willing, M. Sowers, and D. Aron Bone mineral density and its change in white women: estrogen and Vitamin D receptor genotypes and their interaction J Bone Miner Res 13 4 1998 695 705
29. Y.J. Qin, Z.L. Zhang, and Q.R. Huang Association of Vitamin D receptor and estrogen receptor-alpha gene polymorphism with peak bone mass and bone size in Chinese women Acta Pharmacol Sin 25 4 2004 462 468
30. P. Garnero, E. Hausherr, and M.C. Chapuy Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study J Bone Miner Res 11 10 1996 1531 1538
31. H.W. Deng, J. Li, and J.L. Li Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with Vitamin D receptor and estrogen receptor genotypes Hum Genet 103 5 1998 576 585
32. M.A. Brown, M.A. Haughton, S.F. Grant, A.S. Gunnell, N.K. Henderson, and J.A. Eisman Genetic control of bone density and turnover: role of the collagen 1alpha1, estrogen receptor, and Vitamin D receptor genes J Bone Miner Res 16 4 2001 758 764
33. C. Hassager, S.B. Jensen, and C. Christiansen Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: do they exist? Osteoporos Int 4 1 1994 36 41
34. C.J. Rosen, and C.R. Kessenich The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy Endocrinol Metab Clin North Am 26 2 1997 295 311
35. D.M. Herrington, T.D. Howard, and K.B. Brosnihan Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein Circulation 105 16 2002 1879 1882
36. S.C. Schuit, H.H. Oei, and J.C. Witteman Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction JAMA 291 24 2004 2969 2977